The Company was originally incorporated as Private Limited, under the Companies Act, 1956 ("Companies Act") in the name and style of "M/s Infinium Pharmachem Private Limited" on November 21st, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Ahmedabad, Gujarat. Later on, company was converted into public limiteds company, the name of the Company was changed to "Infinium Pharmachem Limited" and fresh Certificate of Incorporation dated August 12th, 2022 was issued by the Registrar of Companies, Ahmedabad, Gujarat.
Infinium Pharmachem Limited, well focused to Iodine chemistry & this is the only core area of ours. We are working as CRAMS, but the domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination.
The company also providing fully integrated customized services from R & D to Commercial scale manufacturing and packaging for our products to the Pharmaceutical, Agrochemical,Nutraceutical, Speciality Chemicals & various other chemical Industries.The supply range of Iodine derivatives on Order to Made basis only. However, we keep in ready stock many of well demanded products.
MAJOR EVENTS :
2003
- Established with a vision to be a globally integrated and admired Pharmaceutical and Healthcare Company.
2004
-Started iodine derivatives manufacturing plant at Gujarat, India.
2010
-Set up R & D Unit and Certified as ISO 90001-2008.
2011
- Penetrated the Pharmaceutical market with the CRAMS model.
2014
- Upgraded Plant with GMP compliant large scale manufacturing facility.
2015
-Obtained FDA approval for manufacturing of APIs.
2017
-Certified as WHO-GMP and ISO 14001-2015.
2018
-Product Portfolio touched 200+ Iodine Derivatives and 7+ APIs.
2019
-Expanded reach to over 15+ countries across the globe.
2021
-Augmentation of production capacity and construction of new Premises.
2022
- Incorporated subsidiary company in bio-fuel segment for backwar
2023
-The Company has issued Bonus Shares in the Ratio of 1:1.
- 'Commencement Of Production By Subsidiary Company'.
2024
-Infinium Pharmachem Ltd CommencesConstruction of New Project for manufacturing Contrast Media Raw Materials.
-Infinium Pharmachem Limited has informed the Exchange about Acquisition of equity shares of Infinium Healthcare Private Limited.